NCT06960798 Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)
| NCT ID | NCT06960798 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oklahoma |
| Condition | Prostate Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2026-05-02 |
| Primary Completion | 2028-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2026-05-02 with a primary completion date of 2028-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prostate cancer. By examining these samples, researchers hope to understand how different genes in your tumor can influence treatment decisions, how your cancer progresses and the outcome of your cancer.
Eligibility Criteria
Inclusion Criteria: * Written informed consent signed and dated by the patient prior to the performance of any study-specific procedures, sampling, or analyses. * At least 18 years-of-age at the time of signature of the informed consent form (ICF). * Patients who self-identify as Native American. * Patients with a pathologically proven diagnosis of PC (any stage). * Availability of most recent archived tumor samples. Exclusion Criteria: * Patients not of Native American descent or identity. * Patient does not have archival tissue available.
Contact & Investigator
Adanma Ayanambakkam, MD
PRINCIPAL INVESTIGATOR
University of Oklahoma
Frequently Asked Questions
Who can join the NCT06960798 clinical trial?
This trial is open to male participants only, aged 18 Years or older, up to 100 Years, studying Prostate Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06960798 currently recruiting?
Yes, NCT06960798 is actively recruiting participants. Contact the research team at SCC-IIT-Office@ouhsc.edu for enrollment information.
Where is the NCT06960798 trial being conducted?
This trial is being conducted at Oklahoma City, United States.
Who is sponsoring the NCT06960798 clinical trial?
NCT06960798 is sponsored by University of Oklahoma. The principal investigator is Adanma Ayanambakkam, MD at University of Oklahoma. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.